Determining the Threshold for HbA1c as a Predictor for Adverse Outcomes After Total Joint Arthroplasty: A Multicenter, Retrospective Study
- 1 September 2017
- journal article
- research article
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 32 (9) , S263-S267.e1
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hemoglobin A1C as a Marker for Surgical Risk in Diabetic Patients Undergoing Total Joint ArthroplastyThe Journal of Arthroplasty, 2013
- Relations between Long-term Glycemic Control and Postoperative Wound and Infectious Complications after Total Knee Arthroplasty in Type 2 DiabeticsClinics in Orthopedic Surgery, 2013
- Disease burden of prosthetic joint infections after hip and knee joint replacement in Finland during 1999–2004: capture–recapture estimationJournal of Hospital Infection, 2010
- The Impact of Glycemic Control and Diabetes Mellitus on Perioperative Outcomes After Total Joint ArthroplastyJournal of Bone and Joint Surgery, 2009
- Low rate of infected knee replacements in a nationwide series—is it an underestimate?Acta Orthopaedica, 2009
- The Impact of Diabetes on Perioperative Patient Outcomes After Total Hip and Total Knee Arthroplasty in the United StatesThe Journal of Arthroplasty, 2008
- Looks Good But Feels Bad: Factors That Contribute to Poor Results After Total Knee ArthroplastyThe Journal of Arthroplasty, 2007
- Youden Index and the optimal threshold for markers with mass at zeroStatistics in Medicine, 2007
- Incidence and Timing of Myocardial Infarction After Total Joint ArthroplastyThe Journal of Arthroplasty, 2006
- Total Knee Replacement in Patients With Diabetes MellitusClinical Orthopaedics and Related Research, 2003